Adverse event reporting in randomised controlled trials of neuropathic pain: Considerations for future practice

Cornelius VR, Sauzet O, Williams JE, Ayis S, Farquhar-Smith P, Ross JR, Branford RA, Peacock JL (2013)
Pain 154(2): 213-220.

Journal Article | Published | English

No fulltext has been uploaded

Author
; ; ; ; ; ; ;
Abstract
High-quality information on the potential benefit and harm of a drug is required for patients and clinicians to make informed treatment decisions and to enable cost-effectiveness modeling to be undertaken. This systematic review describes the collection and reporting of adverse event data as presented in published clinical trials of neuropathic pain for the evaluation of antidepressant or antiepileptic drugs. A total of 74 studies in 16,323 patients published between 1965 and 2012 were identified, of which 43 were published from 2004 onwards. The review found that methods used to collect adverse event data, the frequency of collection, and the selection criteria used by authors for reporting adverse events vary substantially, and these events are often inadequately reported. Consequently, a potential synthesis of valuable harm information across trials is hampered. We make recommendations regarding the reporting of methods used to collect, assess, select, and present adverse event data in publications. Through the Core Outcome Measures in Effectiveness Trials (COMET) initiative, core outcome sets (which include effectiveness and harm) are developed by disease condition. To facilitate data synthesis for adverse events of drug therapies, we suggest that core outcome sets for harms could be developed by therapeutic class (ie, individualized for each class of drug). To improve comparability of information across trials collection methods need to be standardized for patient reports (spontaneous or prompted) and active surveillance (clinical examinations and laboratory tests). Uniform methods for presenting summary information regarding recurrent events, duration and timing of events requires further research. (C) 2012 International Association for the Study of Pain. Published by Elsevier B.V. All rights reserved.
Publishing Year
ISSN
PUB-ID

Cite this

Cornelius VR, Sauzet O, Williams JE, et al. Adverse event reporting in randomised controlled trials of neuropathic pain: Considerations for future practice. Pain. 2013;154(2):213-220.
Cornelius, V. R., Sauzet, O., Williams, J. E., Ayis, S., Farquhar-Smith, P., Ross, J. R., Branford, R. A., et al. (2013). Adverse event reporting in randomised controlled trials of neuropathic pain: Considerations for future practice. Pain, 154(2), 213-220.
Cornelius, V. R., Sauzet, O., Williams, J. E., Ayis, S., Farquhar-Smith, P., Ross, J. R., Branford, R. A., and Peacock, J. L. (2013). Adverse event reporting in randomised controlled trials of neuropathic pain: Considerations for future practice. Pain 154, 213-220.
Cornelius, V.R., et al., 2013. Adverse event reporting in randomised controlled trials of neuropathic pain: Considerations for future practice. Pain, 154(2), p 213-220.
V.R. Cornelius, et al., “Adverse event reporting in randomised controlled trials of neuropathic pain: Considerations for future practice”, Pain, vol. 154, 2013, pp. 213-220.
Cornelius, V.R., Sauzet, O., Williams, J.E., Ayis, S., Farquhar-Smith, P., Ross, J.R., Branford, R.A., Peacock, J.L.: Adverse event reporting in randomised controlled trials of neuropathic pain: Considerations for future practice. Pain. 154, 213-220 (2013).
Cornelius, Victoria R., Sauzet, Odile, Williams, John E., Ayis, Salma, Farquhar-Smith, Paul, Ross, Joy R., Branford, Ruth A., and Peacock, Janet L. “Adverse event reporting in randomised controlled trials of neuropathic pain: Considerations for future practice”. Pain 154.2 (2013): 213-220.
This data publication is cited in the following publications:
This publication cites the following data publications:

6 Citations in Europe PMC

Data provided by Europe PubMed Central.

Adverse event reporting in nonpharmacologic, noninterventional pain clinical trials: ACTTION systematic review.
Hunsinger M, Smith SM, Rothstein D, McKeown A, Parkhurst M, Hertz S, Katz NP, Lin AH, McDermott MP, Rappaport BA, Turk DC, Dworkin RH., Pain 155(11), 2014
PMID: 25123543
Relation of completeness of reporting of health research to journals' endorsement of reporting guidelines: systematic review.
Stevens A, Shamseer L, Weinstein E, Yazdi F, Turner L, Thielman J, Altman DG, Hirst A, Hoey J, Palepu A, Schulz KF, Moher D., BMJ 348(), 2014
PMID: 24965222
Tramadol and acetaminophen combination for chronic non-cancer pain.
Farquhar-Smith P, Gubbay A., Expert Opin Pharmacother 14(16), 2013
PMID: 24067074
Adverse event assessment, analysis, and reporting in recent published analgesic clinical trials: ACTTION systematic review and recommendations.
Smith SM, Wang AT, Katz NP, McDermott MP, Burke LB, Coplan P, Gilron I, Hertz SH, Lin AH, Rappaport BA, Rowbotham MC, Sampaio C, Sweeney M, Turk DC, Dworkin RH., Pain 154(7), 2013
PMID: 23602344

17 References

Data provided by Europe PubMed Central.

Reporting of harm in randomized controlled trials published in the urological literature.
Breau RH, Gaboury I, Scales CD Jr, Fesperman SF, Watterson JD, Dahm P., J. Urol. 183(5), 2010
PMID: 20299044
Adverse event reporting in acupuncture clinical trials focusing on pain.
Capili B, Anastasi JK, Geiger JN., Clin J Pain 26(1), 2010
PMID: 20026952
Reporting of adverse events in randomized controlled trials of highly active antiretroviral therapy: systematic review.
Chowers MY, Gottesman BS, Leibovici L, Pielmeier U, Andreassen S, Paul M., J. Antimicrob. Chemother. 64(2), 2009
PMID: 19477890
Core outcome measures for chronic pain clinical trials: IMMPACT recommendations.
Dworkin RH, Turk DC, Farrar JT, Haythornthwaite JA, Jensen MP, Katz NP, Kerns RD, Stucki G, Allen RR, Bellamy N, Carr DB, Chandler J, Cowan P, Dionne R, Galer BS, Hertz S, Jadad AR, Kramer LD, Manning DC, Martin S, McCormick CG, McDermott MP, McGrath P, Quessy S, Rappaport BA, Robbins W, Robinson JP, Rothman M, Royal MA, Simon L, Stauffer JW, Stein W, Tollett J, Wernicke J, Witter J; IMMPACT., Pain 113(1-2), 2005
PMID: 15621359
Reporting of adverse effects in clinical trials should be improved: lessons from acute postoperative pain.
Edwards JE, McQuay HJ, Moore RA, Collins SL., J Pain Symptom Manage 18(6), 1999
PMID: 10641469
Better reporting of harms in randomized trials: an extension of the CONSORT statement.
Ioannidis JP, Evans SJ, Gotzsche PC, O'Neill RT, Altman DG, Schulz K, Moher D; CONSORT Group., Ann. Intern. Med. 141(10), 2004
PMID: 15545678
Adverse events: the more you search, the more you find.
Ioannidis JP, Mulrow CD, Goodman SN., Ann. Intern. Med. 144(4), 2006
PMID: 16490917
The development of standardized case definitions and guidelines for adverse events following immunization.
Kohl KS, Gidudu J, Bonhoeffer J, Braun MM, Buettcher M, Chen RT, Drammeh B, Duclos P, Heijbel H, Heininger U, Hummelman E, Jefferson T, Keller-Stanislawski B, Loupi E, Marcy SM., Vaccine 25(31), 2007
PMID: 17400339
Reporting bias in medical research - a narrative review.
McGauran N, Wieseler B, Kreis J, Schuler YB, Kolsch H, Kaiser T., Trials 11(), 2010
PMID: 20388211

Papanikolaou, Can Med Assoc J 174(), 2006
Reporting of safety results in published reports of randomized controlled trials.
Pitrou I, Boutron I, Ahmad N, Ravaud P., Arch. Intern. Med. 169(19), 2009
PMID: 19858432
Reporting of adverse events in randomised controlled trials of antiepileptic drugs using the CONSORT criteria for reporting harms.
Shukralla AA, Tudur-Smith C, Powell GA, Williamson PR, Marson AG., Epilepsy Res. 97(1-2), 2011
PMID: 22000868
Core outcome domains for chronic pain clinical trials: IMMPACT recommendations.
Turk DC, Dworkin RH, Allen RR, Bellamy N, Brandenburg N, Carr DB, Cleeland C, Dionne R, Farrar JT, Galer BS, Hewitt DJ, Jadad AR, Katz NP, Kramer LD, Manning DC, McCormick CG, McDermott MP, McGrath P, Quessy S, Rappaport BA, Robinson JP, Royal MA, Simon L, Stauffer JW, Stein W, Tollett J, Witter J., Pain 106(3), 2003
PMID: 14659516

Export

0 Marked Publications

Open Data PUB

Web of Science

View record in Web of Science®

Sources

PMID: 23127360
PubMed | Europe PMC

Search this title in

Google Scholar